|

niraparib/abiraterone acetate Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Maryland, Baltimore1

Indications

  • Oligometastatic Disease1
  • Prostate Cancer1
  • Cancer1

Baltimore, Maryland1 trial

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

University of Maryland Greenebaum Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.